Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease
Frederic Sampedro, Rocío Pérez‐González, Saül Martínez‐Horta, et al.
Parkinsonism & Related Disorders (2020) Vol. 74, pp. 43-49
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Blood neurofilament light: a critical review of its application to neurologic disease
Christian Barro, Tanuja Chitnis, Howard L. Weiner
Annals of Clinical and Translational Neurology (2020) Vol. 7, Iss. 12, pp. 2508-2523
Open Access | Times Cited: 195
Diffusion Tensor Imaging in Parkinson's Disease and Parkinsonian Syndrome: A Systematic Review
Yu Zhang, Marc A. Burock
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 76
Neurofilaments Light Chain in Neurodegenerative Dementias: A Review of Imaging Correlates
Chiara Gallingani, Chiara Carbone, Manuela Tondelli, et al.
Brain Sciences (2024) Vol. 14, Iss. 3, pp. 272-272
Open Access | Times Cited: 13
Serum NFL levels predict progression of motor impairment and reduction in putamen dopamine transporter binding ratios in de novo Parkinson's disease: An 8-year longitudinal study
Rong Ye, Joseph J. Locascio, Anna E. Goodheart, et al.
Parkinsonism & Related Disorders (2021) Vol. 85, pp. 11-16
Open Access | Times Cited: 42
Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson’s disease dementia
Irene Frigerio, Max A. Laansma, Chen‐Pei Lin, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson’s disease
Shuai Mao, Xing Teng, Zhen Li, et al.
Brain Research (2023) Vol. 1805, pp. 148271-148271
Closed Access | Times Cited: 16
Neurofilament Light Protein Predicts Disease Progression in Idiopathic REM Sleep Behavior Disorder
Xuan Zhang, Li Ma, Danqi Liang, et al.
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 4, pp. 485-499
Open Access | Times Cited: 16
Serum Neurofilament Dynamics Predicts Cognitive Progression in de novo Parkinson’s Disease
Lingzhi Ma, Can Zhang, Han Wang, et al.
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 3, pp. 1117-1127
Closed Access | Times Cited: 38
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease
Andrea Pilotto, Alberto Imarisio, F. L. Conforti, et al.
Parkinsonism & Related Disorders (2021) Vol. 87, pp. 41-47
Open Access | Times Cited: 38
Cortical Thickness and Serum NfL Explain Cognitive Dysfunction in Newly Diagnosed Patients With Multiple Sclerosis
Álvaro Javier Cruz-Gómez, Lucía Forero, Elena Lozano-Soto, et al.
Neurology Neuroimmunology & Neuroinflammation (2021) Vol. 8, Iss. 6
Open Access | Times Cited: 34
Increased homocysteine levels correlate with cortical structural damage in Parkinson's disease
Frederic Sampedro, Saül Martínez‐Horta, Andrea Horta‐Barba, et al.
Journal of the Neurological Sciences (2022) Vol. 434, pp. 120148-120148
Open Access | Times Cited: 23
Association of Neurofilament Light With the Development and Severity of Parkinson Disease
Shannon Halloway, Pankaja Desai, Todd Beck, et al.
Neurology (2022) Vol. 98, Iss. 22
Open Access | Times Cited: 22
The potential use of plasma NfL as a diagnostic and prognostic biomarker of fatigue in early Parkinson’s disease
Ning-Ning Che, Jingxuan Huang, Shichan Wang, et al.
Therapeutic Advances in Neurological Disorders (2025) Vol. 18
Open Access
Neurofilament light as a biomarker for motor decline in Parkinson’s disease
Yumei Liu, Kaixin Dou, Ling Xue, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 21
Outcome Measures for Disease-Modifying Trials in Parkinson’s Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative
Cristina González-Robles, Rimona S. Weil, Daniel J. van Wamelen, et al.
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 6, pp. 1011-1033
Open Access | Times Cited: 11
Cortical Macro‐ and Microstructural Changes in Parkinson's Disease with Probable Rapid Eye Movement Sleep Behavior Disorder
Jèssica Pardo, Víctor Montal, Anna Campabadal, et al.
Movement Disorders (2024) Vol. 39, Iss. 5, pp. 814-824
Open Access | Times Cited: 4
Associations of sleep disorders with serum neurofilament light chain levels in Parkinson’s disease
Wan-Yi Qi, Yan Sun, Yun Guo, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson's disease
Javier Pagonabarraga, Rocío Pérez‐González, Helena Bejr‐Kasem, et al.
Parkinsonism & Related Disorders (2022) Vol. 105, pp. 132-138
Closed Access | Times Cited: 18
Association of Cortical and Subcortical Microstructure With Clinical Progression and Fluid Biomarkers in Patients With Parkinson Disease
Linbo Wang, Cheng Zhou, Wei Zhang, et al.
Neurology (2023) Vol. 101, Iss. 3
Open Access | Times Cited: 10
Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson's disease
Daniele Urso, Lucia Batzu, Giancarlo Logroscino, et al.
Neurobiology of Disease (2023) Vol. 185, pp. 106237-106237
Open Access | Times Cited: 10
Neurofilaments – Small proteins of physiological significance and predictive power for future neurodegeneration and cognitive decline across the life span
Julia Elmers, Lorenza S. Colzato, Katja Akgün, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102037-102037
Closed Access | Times Cited: 10
Association between plasma neurofilament light chain levels and cognitive function in patients with Parkinson's disease
Yongyun Zhu, Baiyuan Yang, Fang Wang, et al.
Journal of Neuroimmunology (2021) Vol. 358, pp. 577662-577662
Closed Access | Times Cited: 18
Electrochemical immunoplatform to unravel neurodegeneration and Alzheimer's disease through the determination of neurofilament light protein
Alejandro Valverde, Ana Montero‐Calle, Rodrigo Barderas, et al.
Electrochimica Acta (2021) Vol. 371, pp. 137815-137815
Closed Access | Times Cited: 16
Estimated glomerular filtration rate is a biomarker of cognitive impairment in Parkinson’s disease
Yi Qu, Qixiong Qin, Dan-Lei Wang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 6
Cortical microstructural correlates of plasma neurofilament light chain in Huntington's disease
Frederic Sampedro, Jesús Pérez‐Pérez, Saül Martínez‐Horta, et al.
Parkinsonism & Related Disorders (2021) Vol. 85, pp. 91-94
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top